Common anticholinergics linked to cognitive decline include meclizine, scopolamine, biperiden, oxybutynin, and diphenhydramine. In contrast, others such as glycopyrronium and tiotropium have not shown these effects. Patients and doctors should carefully weigh the risks and benefits of these medications.
Corticosteroids and the Brain:
Corticosteroids are used to treat various inflammatory and autoimmune diseases. However, prolonged use, especially orally, can cause serious side effects such as disorientation, anxiety, and depression. A British study found that people taking corticosteroids long-term had a higher risk of developing dementia.
Glucocorticoids like prednisone affect brain function by altering levels of cortisol, a stress hormone. Even inhaled corticosteroids like fluticasone can have negative effects if used in high doses or for a long period. It is essential that healthcare professionals closely monitor their use and consider alternative treatments.
Benzodiazepines: A Silent Risk to Memory.
Benzodiazepines, such as alprazolam and diazepam, are prescribed to treat insomnia and anxiety. While effective in the short term, their prolonged use can double the risk of Alzheimer's disease and cause permanent brain damage. One study showed that 40% of people using these medications experienced various neurological symptoms, such as difficulty concentrating.
They are also associated with risks of physical and emotional dependence, making them difficult for many patients to stop taking. Physicians should consider non-pharmacological treatments such as behavioral therapy to treat anxiety and insomnia.
Amphetamines and the Memory Trap:
Amphetamines are used to treat attention deficit hyperactivity disorder (ADHD). While they temporarily improve concentration, prolonged use can lead to memory loss and other lasting cognitive damage. They create physical and emotional dependence and can cause serious problems such as heart arrhythmias.
Read more on the next page
